-
New York pressures retail pharmacies to provide abortion pills
New York Gov. Kathy Hochul and Attorney General Letitia James asked CVS, Walgreens and Rite Aid to promise they will sell the abortion medication mifepristone as other state attorneys general work to block the drug's distribution. -
Shortage of 86% of local anesthetics sees another delay
The ongoing shortage of local anesthetics, including bupivacaine and lidocaine solutions, has been extended, drugmakers told the American Society of Health-System Pharmacists. -
Eli Lilly to halt development of Alzheimer's treatment candidate
Eli Lilly is halting development of solanezumab after it failed to slow cognitive decline in a study of patients at risk of Alzheimer's disease, the drugmaker said March 8. -
Essentia Health to open new 16,000-square-foot clinic, pharmacy combo
Duluth, Minn.-based Essentia Health announced new plans to open a 16,000-square-foot clinic and drive-through pharmacy in Staples, Minn. -
AHA pushes back on new 340B alliance
Community health centers, healthcare advocacy groups and a pharmaceutical lobby created an alliance aimed at protecting 340B, a drug-pricing program for eligible hospitals. Hospitals aren't a fan of the alliance. -
California rescinds $54M deal with Walgreens
California Gov. Gavin Newsom withdrew a contract with Walgreens worth $54 million on March 8 after the national pharmacy chain shared conflicting plans for dispensing abortion pills. -
FDA chimes in on albuterol shortage
In a March 8 Twitter thread, the FDA acknowledged it's aware of a potential drug supply disruption after Gurnee, Ill.-based Akorn Operating Co. closed in late February. -
Amoxicillin shortage continues as resupply dates are delayed again
An ongoing national shortage of amoxicillin has again been further exacerbated by resupply delays. -
Drugmaker to pull only preterm birth drug from market
Covis Pharma will stop selling Makena, the only FDA-approved drug to prevent preterm births, months after a panel voted 14-1 to retract the treatment, according to The Wall Street Journal. -
5 Ozempic updates
Ozempic, a diabetes treatment that has caught the attention of Elon Musk, TikTokers and WeightWatchers for its off-label use of weight loss, has landed in five recent headlines: -
Moderna may test its bird flu, mpox vaccines in humans in 2023
Moderna is eyeing testing two vaccine candidates, one for mpox and another for bird flu, in humans later this year, Bloomberg reported March 6. -
Cuban breaks into brand-name drug market
Mark Cuban Cost Plus Drug Co. has entered into an agreement with IBSA Pharma to sell Tirosint, a medication for hypothyroidism. It will be the first brand-name drug offered by Mr. Cuban's pharmacy. -
FDA to question popular decongestant's efficacy
An FDA advisory panel will discuss in April the efficacy of a popular over-the-counter decongestant, phenylephrine, amid concerns the oral drug does not work. -
Nephron making albuterol 'as fast as possible' amid shortage
In response to Akorn Operating Co.'s sudden closure, Nephron Pharmaceuticals told Becker's the company is working to boost supply of albuterol. -
'We're done': California cuts ties with Walgreens over abortion pills
California Gov. Gavin Newsom said the state will not do business with Walgreens following confusion over whether the pharmacy retailer will distribute abortion pills. -
FDA expects to rule on full approval for Alzheimer's drug by July
The FDA is set to decide whether to fully approve Leqembi, Eisai and Biogen's Alzheimer's treatment by July 6, CNBC reported March 6. -
American Diabetes Association puts Wegovy, Ozempic as preferred treatments
After years of promoting another drug, the American Diabetes Association updated its guidelines to put Wegovy and diabetes medication Ozempic as the preferred treatments for Type 2 diabetes, The Wall Street Journal reported March 5. -
5 pharmacy execs recently promoted to C-suite roles
Four health systems and hospitals have recently promoted pharmacy leaders: -
Illinois to probe drugmaker after it laid off hundreds
Illinois plans to investigate Akorn Operating Co. after the drugmaker laid off hundreds of workers in late February, according to The Center Square. -
Walgreens reverses plan to dispense abortion pills in some states
Walgreens will not dispense abortion pills in several states where they remain legal. The move comes in response to pressure from Republican attorneys general, who last month wrote a letter to the company threatening legal action if it begins dispensing the drugs, Politico reported March 3.
Page 47 of 50